198 related articles for article (PubMed ID: 32433496)
1. In silico identification of MAPK14-related lncRNAs and assessment of their expression in breast cancer samples.
Dashti S; Taherian-Esfahani Z; Kholghi-Oskooei V; Noroozi R; Arsang-Jang S; Ghafouri-Fard S; Taheri M
Sci Rep; 2020 May; 10(1):8316. PubMed ID: 32433496
[TBL] [Abstract][Full Text] [Related]
2. Expression analysis of vimentin and the related lncRNA network in breast cancer.
Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
[TBL] [Abstract][Full Text] [Related]
3. Abnormal expression of MAPK14-related lncRNAs in the peripheral blood of patients with multiple sclerosis.
Ghafouri-Fard S; Gholipour M; Eslami S; Hussen BM; Taheri M; Samadian M; Omrani MD
Noncoding RNA Res; 2023 Sep; 8(3):335-339. PubMed ID: 37091283
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer.
Dashti S; Ghafouri-Fard S; Esfandi F; Oskooei VK; Arsang-Jang S; Taheri M
Exp Mol Pathol; 2020 Feb; 112():104359. PubMed ID: 31837323
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA and LncRNA Expression Profiles in Human Estrogen Receptor Positive Breast Cancer.
Shao X; Huang P; Shi L; Lei L; Cao W; Chen Z; Wang X; Zheng Y
Clin Lab; 2019 Jan; 65(1):. PubMed ID: 30775882
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis of Rho GTPase-related lncRNAs in breast cancer.
Nicknam A; Khojasteh Pour S; Hashemnejad MA; Hussen BM; Safarzadeh A; Eslami S; Taheri M; Ghafouri-Fard S; Jamali E
Pathol Res Pract; 2023 Apr; 244():154429. PubMed ID: 36996609
[TBL] [Abstract][Full Text] [Related]
7. Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer.
Ghafouri-Fard S; Taherian-Esfahani Z; Dashti S; Kholghi Oskooei V; Taheri M; Samsami M
Exp Mol Pathol; 2020 Jun; 114():104415. PubMed ID: 32165090
[TBL] [Abstract][Full Text] [Related]
8. Expression analysis of AFAP1-AS1 and AFAP1 in breast cancer.
Dianatpour A; Faramarzi S; Geranpayeh L; Mirfakhraie R; Motevaseli E; Ghafouri-Fard S
Cancer Biomark; 2018; 22(1):49-54. PubMed ID: 29439313
[TBL] [Abstract][Full Text] [Related]
9. Expression of long noncoding RNAs in breast cancer in relation to reproductive factors and tumor characteristics.
Ghafouri-Fard S; Taheri M; Omrani MD; Kholghi Oskooei V
J Cell Biochem; 2019 Aug; 120(8):13965-13973. PubMed ID: 30957286
[TBL] [Abstract][Full Text] [Related]
10. Assessment of expression of interferon γ (IFN-G) gene and its antisense (IFNG-AS1) in breast cancer.
Yaghoobi H; Azizi H; Oskooei VK; Taheri M; Ghafouri-Fard S
World J Surg Oncol; 2018 Oct; 16(1):211. PubMed ID: 30336781
[TBL] [Abstract][Full Text] [Related]
11. Expression assessment of a panel of long non-coding RNAs in gastric malignancy.
Esfandi F; Salehnezhad T; Taheri M; Afsharpad M; Hafez AA; Oskooei VK; Ghafouri-Fard S
Exp Mol Pathol; 2020 Apr; 113():104383. PubMed ID: 31982396
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA NORAD inhibition upregulates microRNA-323a-3p to suppress tumorigenesis and development of breast cancer through the PUM1/eIF2 axis.
Shi P; Zhang J; Li X; Li W; Li H; Fu P
Cell Cycle; 2021 Jul; 20(13):1295-1307. PubMed ID: 34125645
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
15. Identification of expression of CCND1-related lncRNAs in breast cancer.
Hussen BM; Hidayat HJ; Ghafouri-Fard S
Pathol Res Pract; 2022 Aug; 236():154009. PubMed ID: 35803208
[TBL] [Abstract][Full Text] [Related]
16. Expression Analysis of Long Non-Coding RNAs Related With FOXM1, GATA3, FOXA1 and ESR1 in Breast Tissues.
Hassani B; Taheri M; Asgari Y; Zekri A; Sattari A; Ghafouri-Fard S; Pouresmaeili F
Front Oncol; 2021; 11():671418. PubMed ID: 34094972
[TBL] [Abstract][Full Text] [Related]
17. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
[TBL] [Abstract][Full Text] [Related]
18. Identification of Potential Long Non-Coding RNA Candidates that Contribute to Triple-Negative Breast Cancer in Humans through Computational Approach.
Rahman MM; Hossain MT; Reza MS; Peng Y; Feng S; Wei Y
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830241
[TBL] [Abstract][Full Text] [Related]
19. Opposite trends of GAS6 and GAS6-AS expressions in breast cancer tissues.
Lavasani A; Hussen BM; Taheri F; Sattari A; Yousefi H; Omrani MD; Nazer N; Ghafouri-Fard S; Taheri M
Exp Mol Pathol; 2021 Feb; 118():104600. PubMed ID: 33359886
[TBL] [Abstract][Full Text] [Related]
20. Expression profiling revealed up-regulation of three lncRNAs in breast cancer samples.
Mohebi M; Sattari A; Ghafouri-Fard S; Modarressi MH; Kholghi-Oskooei V; Taheri M
Exp Mol Pathol; 2020 Dec; 117():104544. PubMed ID: 32976818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
